Risk factors associated with hepatocellular carcinoma in primary biliary cirrhosis

Hepatology

Volumn 58, Issue 4, 2013, Pages 1520-1521

  Floreani, Annarosa ^a   Farinati, Fabio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; URSODEOXYCHOLIC ACID;

AUTOIMMUNE DISEASE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER STAGING; COMORBIDITY; DISEASE ASSOCIATION; HUMAN; LETTER; LIVER CELL CARCINOMA; MEASUREMENT ACCURACY; META ANALYSIS (TOPIC); PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SYSTEMATIC REVIEW (TOPIC); TREATMENT RESPONSE;

CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER NEOPLASMS; MALE; PRECANCEROUS CONDITIONS;

EID: 84884979010     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26355     Document Type: Letter

References (2)

1. Liang Y, Yang Z, Zhong R. Primary biliary cirrhosis and cancer risk: a systematic review and meta-analysis. Hepatology 2012;56:1409-1417.
2. Farinati F, Floreani A, De Maria N, Fagiuoli S, Naccarato R, Chiaramonte M. Hepatocellular carcinoma in primary biliary cirrhosis. J Hepatol 1994;21:315-316.